Q4 2021 Hansa Biopharma AB Earnings Call Transcript
Hello, everyone, and welcome to the Hansa Biopharma Year-end Report for January through December 2021. (Operator Instructions) Today, I am pleased to present CEO, Søren Tulstrup.
Speakers, please begin.
¸ - ()-&
Thank you, operator. Good afternoon, Good morning, and welcome to the Hansa Biopharma conference call reporting the year-end results for 2021. I'm Søren Tulstrup, CEO of Hansa Biopharma. With me today, I have our CFO, Donato Spota; as well as our Head of Investor Relations, Klaus Sindahl.
Today, we'll review the overall progress and highlights of our business in the most recent quarter and provide a preview of our near-term milestones. Our presentation should take approximately 20 minutes, and after that we'll take your questions. Now please turn to Slide 2. Please allow me to draw your attention to the fact that I'll be making forward-looking statements during this presentation, and you should therefore apply
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |